OC
BNGO icon

Oppenheimer & Co’s Bionano Genomics BNGO Stock Holding History

Oppenheimer & Co’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-63
Closed -$22.9K – 1384
2023
Q2 		$22.9K Buy
63
+1
+2% +$451 ﹤0.01% 1401
2023
Q1 		$41.6K Sell
62
-1
-2% -$888 ﹤0.01% 1350
2022
Q4 		$55.1K Sell
63
-2
-3% -$2.52K ﹤0.01% 1310
2022
Q3 		$71K Buy
65
+2
+3% +$2.64K ﹤0.01% 1313
2022
Q2 		$52K Sell
63
-47
-43% -$48.4K ﹤0.01% 1363
2022
Q1 		$171K Sell
110
-50
-31% -$67.5K ﹤0.01% 1375
2021
Q4 		$287K Sell
160
-186
-54% -$497K 0.01% 1242
2021
Q3 		$1.14M Hold
346
– – 0.02% 699
2021
Q2 		$1.52M Buy
346
+268
+344% +$1.06M 0.03% 597
2021
Q1 		$380K Buy
+78
New +$440K 0.01% 1082

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Oppenheimer & Co's BNGO Position: Q3 2023 in Review

Oppenheimer & Co sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 63 shares — an estimated $22.9K sold.

Oppenheimer & Co first reported a position in BNGO in Q1 2021 and held it in 10 quarters. The position peaked at $1.52M in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Oppenheimer & Co reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 63 Bionano Genomics shares in Q3 2023, an estimated $22.9K.
  • Oppenheimer & Co first reported a position in Bionano Genomics in Q1 2021 and held it in 10 quarters.
  • Oppenheimer & Co's Bionano Genomics position peaked at $1.52M in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.